// App-Quantinova.ai

1260 : Hydroxychloroquine Reduces the Risk of Coronary Artery Disease in Patients with Rheumatoid Arthritis

Researchers

Presenter

  • Li Chun

Principal Investigators

  • Mu Rong

  • Su Yin

  • Li Zhenbin

  • Li Junfang

  • Zhang Fengxiao

  • Han Shuling

  • Lin Jinying

  • Li Xiaofeng

  • Wang Yongfu

  • Wang Guochun

  • Zhu Ping

  • Liu Xiangyuan

  • Chen Haiying

  • Cui Liufu

  • Zhang Zhuoli

Medical Centers

  • Department of Gastroenterology, 1st Affiliated Hospital, Sun Yat-sen University, Guangzhou, China

  • Department of Rheumatology and Immunology,Peace Hospital, Shijiazhuang, China

  • Department of Rheumatology and Immunology,Xijing Hospital, Xian, China

  • Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China

  • Department of Rheumatology and Immunology, Baotou, China

  • Department of Rheumatology and Immunology,Peace Hospital, Shijiazhuang, China

  • Department of Rheumatology and Immunology, Baotou, China

  • Department of Rheumatology and Immunology, Peking University Third hospital, Bei jing, China

  • Department of Rheumatology and Immunology,Beijing shunyi hospital of China Medical University, Beijing, China,

Locations

  • China

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Coronary Artery Disease

  • Rheumatoid arthritis

  • Inflammatory Arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

Outcome

  • N/A

Study Design

  • N/A

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved